Durvalumab-induced Myocarditis, Myositis, and Myasthenia Gravis Durvalumab-induced Myocarditis, Myositis, and Myasthenia Gravis

This case reviews the diagnostic workup and management of a patient with severe immune-related adverse effects due to the immune checkpoint inhibitor durvalumab.Journal of Medical Case Reports
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news